Nurse Delivered Cell Phone Adherence Intervention (Pick It UP) (PIU)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Persistent adherence to antiretroviral therapy is necessary for the successful treatment of HIV infection. The proposed research will test a theory-based behavioral intervention that includes objectively monitoring HIV treatment adherence with corrective feedback delivered by cell phone. The study will also test the independent effects of an automated text message reminder system for sustaining adherence improvements. The intervention under study has utility for people living with HIV/AIDS In resource limited rural and urban settings.
| Condition | Intervention | Phase |
|---|---|---|
|
Medication Adherence |
Behavioral: Adherence Counseling Behavioral: General Health Counseling Behavioral: Text Messages |
Phase 1 Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Factorial Assignment Masking: Double Blind (Subject, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Nurse Delivered Cell Phone Adherence Intervention |
- Chart Abstracted Viral Load [ Time Frame: 12 months retrospective ] [ Designated as safety issue: No ]Patient HIV viral load is abstracted from medical records at baseline and at 12-month retrospective follow-up.
- Unannounced Pill Count Adherence [ Time Frame: Monthly ] [ Designated as safety issue: No ]Unannounced phone-based pill counts conducted monthly to obtain an objective measure of medication adherence
| Estimated Enrollment: | 600 |
| Study Start Date: | July 2011 |
| Estimated Study Completion Date: | July 2015 |
| Estimated Primary Completion Date: | July 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Adherence Counseling + Text Messages
Participants receive one office-based adherence counseling session and 4 phone-delivered counseling sessions focused on antiretroviral adherence strategies using a model of behavioral self regulation skills building. Participants also receive follow-up medication reminder text messages delivered by cell phone.
|
Behavioral: Adherence Counseling
5 Sessions of theory-based medication adherence counseling
Behavioral: Text Messages
Daily medication regimen tailored adherence reminders delivered by cell phone
|
|
Experimental: Adherence Counseling Only
Participants receive one office-based adherence counseling session and 4 phone-delivered counseling sessions focused on antiretroviral adherence strategies using a model of behavioral self regulation skills building.
|
Behavioral: Adherence Counseling
5 Sessions of theory-based medication adherence counseling
|
|
Placebo Comparator: General Health Counseling Only
Participants receive one office-based counseling session and 4 phone-delivered counseling sessions focused on general health and nutrition strategies using a model of behavioral self regulation skills building.
|
Behavioral: General Health Counseling
5 sessions of health improvement counseling
|
|
Placebo Comparator: General Health Messages + Text Messages
Participants receive one office-based counseling session and 4 phone-delivered counseling sessions focused on general health and nutrition strategies using a model of behavioral self regulation skills building. Participants also receive follow-up medication reminder text messages delivered by cell phone.
|
Behavioral: General Health Counseling
5 sessions of health improvement counseling
Behavioral: Text Messages
Daily medication regimen tailored adherence reminders delivered by cell phone
|
Detailed Description:
This study is testing a theory-based HIV treatment adherence intervention delivered by cell phone to patients in urban and rural areas. Adherence to antiretroviral (ART) medications is necessary to achieve HIV suppression and non-adherence can lead to treatment resistant genetic variants of HIV. People living with HIV/AIDS often experience difficulty sustaining high-levels of treatment adherence. Most factors that interfere with adherence are unanticipated and occur between clinical visits, including depression, side effects, substance use, and lapses in pharmacy refill. We will conduct a randomized clinical trial to test a cell phone-delivered theory-based medication adherence counseling intervention. The intervention is grounded in Self-Regulation Model and utilizes unannounced pill counts to monitor adherence and guide corrective feedback within the counseling context. Using pill count adherence information for counseling allows providers to detect and correct patient non-adherence within a time frame that can head off viral resistance. An experimental factorial design will test the effects of counseling and a text message reminder system as well the interaction of counseling and text message components with 600 men and women receiving HIV treatment. Following screening, informed consent and baseline assessments participants will be randomized to one of four intervention conditions:(a) self-regulation counseling + regimen tailored text message reminders; (b) self-regulation counseling only; (c) control counseling + regimen tailored text reminders; or (d) control counseling only. The study will therefore use a 2 (self-regulation counseling) x 2 (text message reminders) full factorial deign with participants followed for 9 months post-intervention. The primary endpoints are medication adherence assessed by unannounced pill counts and HIV RNA (viral load). This newly developed intervention strategy is grounded in Self-Regulation Theory and is designed for use in clinical settings with limited resources.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age 18 or older
- Currently taking HIV treatment medication with non-adherence
Exclusion Criteria:
- Under age 18
- Not HIV positive
- Not taking HIV treatment medications
- Adherent to HIV Medications
Contacts and Locations| Contact: Chauncey Cherry, MPH | (404) 892-3500 | chauncey.cherry@share.uconn.edu |
| Contact: Seth C Kalichman, PhD | (860) 486-3706 | seth.k@uconn.edu |
| United States, Connecticut | |
| University of Connecticut | Recruiting |
| Storrs, Connecticut, United States, 06269 | |
| Contact: Chauncey Cherry, MPH 404-892-3500 chauncey.cherry@share.uconn.edu | |
| Contact: Seth Kalichman, PhD (860) 208 3706 seth.k@uconn.edu | |
| Principal Investigator: | Seth C Kalichman, PhD | University of Connecticut |
More Information
No publications provided
| Responsible Party: | Seth Kalichman, Professor, University of Connecticut |
| ClinicalTrials.gov Identifier: | NCT01359280 History of Changes |
| Other Study ID Numbers: | H10-332, 1R01NR012962-01 |
| Study First Received: | May 20, 2011 |
| Last Updated: | December 7, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Connecticut:
|
HIV AIDS Medication Adherence |
ClinicalTrials.gov processed this record on May 22, 2013